Plain-English translation of NCT06616194 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Migraine research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a medication called to see if it can help prevent migraines in teenagers who have frequent headaches. For the first 3 months, about half of participants will take every other day, and the other half will take a placebo (a pill with no medicine in it) that looks identical. After that, everyone who continues will take the medication for another year to make sure it's safe for long-term use.
Teenagers with chronic migraines need better ways to prevent attacks from happening. This medication has shown promise in adults, so researchers want to understand if it's safe and effective for younger patients who suffer from frequent, debilitating headaches.
You'll visit the study clinic about once a month for up to 19 visits over 15 months, though some visits may be at home. At each visit, you'll have a health check and blood test. You'll take either the study medication or placebo every other day, and you'll keep a daily diary to record your migraines. After the first 3 months, if you continue, you'll take the actual medication for another year to see how it works long-term.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
United States